Peripheral Vasodilator Drugs - Global and China Top Players Market Share and Ranking 2023
According to the research report published by Market IntelliX, the global market for Peripheral Vasodilator Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Peripheral Vasodilator Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Peripheral Vasodilator Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Retail Pharmacies grew percent.
Peripheral vasodilator drugs are a class of medications used to treat conditions related to the constriction of blood vessels in the peripheral tissues of the body. These drugs work by relaxing the smooth muscles in the walls of blood vessels.
This report studies and analyses global Peripheral Vasodilator Drugs status and future trends, helps the client to determine the Peripheral Vasodilator Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Peripheral Vasodilator Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Peripheral Vasodilator Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Peripheral Vasodilator Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Peripheral Vasodilator Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Peripheral Vasodilator Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Peripheral Vasodilator Drugs key producing regions, capacity, production, and year over year growth
(6) Peripheral Vasodilator Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Pfizer, Inc.
Novartis AG
GSK plc
AstraZeneca
Merck & Co., Inc.
Sanofi
Bayer AG
Abbott Laboratories
Bristol-Myers Squibb Company
Boehringer Ingelheim International GmbH
Teva Pharmaceutical Industries Ltd.
Viatris, Inc.
Sun Pharmaceutical Industries Ltd.
Lupin
Market segment by Type, covers
Calcium Channel Blockers
Alpha-adrenergic Blockers
Potassium Channel Activators
Others
Market segment by Application, can be divided into
Hospital
Retail Pharmacies
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Peripheral Vasodilator Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Peripheral Vasodilator Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Peripheral Vasodilator Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Peripheral Vasodilator Drugs, percent & CAGR, 2018-2029
Chapter 5: Peripheral Vasodilator Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Peripheral Vasodilator Drugs Definition
1.2 Global Peripheral Vasodilator Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Peripheral Vasodilator Drugs Market Size，2018-2029
1.2.2 By Sales Quantity, Global Peripheral Vasodilator Drugs Market Size，2018-2029
1.2.3 Global Peripheral Vasodilator Drugs Average Selling Price (ASP)，2018-2029
1.3 China Peripheral Vasodilator Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Peripheral Vasodilator Drugs Market Size，2018-2029
1.3.2 By Sales Quantity, China Peripheral Vasodilator Drugs Market Size，2018-2029
1.3.3 China Peripheral Vasodilator Drugs Average Selling Price (ASP)， 2018-2029
1.4 Share of China Peripheral Vasodilator Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Peripheral Vasodilator Drugs Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Peripheral Vasodilator Drugs Market Share in Global, 2018-2029
1.4.3 Peripheral Vasodilator Drugs Market Size: China VS Global, 2018-2029
1.5 Peripheral Vasodilator Drugs Market Dynamics
1.5.1 Peripheral Vasodilator Drugs Market Drivers
1.5.2 Peripheral Vasodilator Drugs Market Restraints
1.5.3 Peripheral Vasodilator Drugs Industry Trends
1.5.4 Peripheral Vasodilator Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Peripheral Vasodilator Drugs, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Peripheral Vasodilator Drugs, Global Market Share by Company, 2018-2023
2.3 Peripheral Vasodilator Drugs Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Peripheral Vasodilator Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Peripheral Vasodilator Drugs Concentration Ratio
2.6 Global Peripheral Vasodilator Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Peripheral Vasodilator Drugs Manufacturers Product Type
2.8 Head Office and Peripheral Vasodilator Drugs Production Site of Key Manufacturer
2.9 Peripheral Vasodilator Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Peripheral Vasodilator Drugs, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Peripheral Vasodilator Drugs, China Market Share by Company, 2018-2023
3.3 China Peripheral Vasodilator Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Peripheral Vasodilator Drugs Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Peripheral Vasodilator Drugs Capacity by Region
4.3 Global Peripheral Vasodilator Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Peripheral Vasodilator Drugs Production by Region, 2018-2029
4.5 Global Peripheral Vasodilator Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Peripheral Vasodilator Drugs Industry Chain
5.2 Peripheral Vasodilator Drugs Upstream Analysis
5.2.1 Peripheral Vasodilator Drugs Core Raw Materials
5.2.2 Main Manufacturers of Peripheral Vasodilator Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Peripheral Vasodilator Drugs Production Mode
5.6 Peripheral Vasodilator Drugs Procurement Model
5.7 Peripheral Vasodilator Drugs Industry Sales Model and Sales Channels
5.7.1 Peripheral Vasodilator Drugs Sales Model
5.7.2 Peripheral Vasodilator Drugs Typical Distributors
6 Sights by Type
6.1 Peripheral Vasodilator Drugs Classification
6.1.1 Calcium Channel Blockers
6.1.2 Alpha-adrenergic Blockers
6.1.3 Potassium Channel Activators
6.1.4 Others
6.2 By Type, Global Peripheral Vasodilator Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Peripheral Vasodilator Drugs Consumption Value, 2018-2029
6.4 By Type, Global Peripheral Vasodilator Drugs Sales Quantity, 2018-2029
6.5 By Type, Global Peripheral Vasodilator Drugs Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Peripheral Vasodilator Drugs Segment by Application
7.1.1 Hospital
7.1.2 Retail Pharmacies
7.1.3 Others
7.2 By Application, Global Peripheral Vasodilator Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Peripheral Vasodilator Drugs Consumption Value, 2018-2029
7.4 By Application, Global Peripheral Vasodilator Drugs Sales Quantity, 2018-2029
7.5 By Application, Global Peripheral Vasodilator Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Peripheral Vasodilator Drugs Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Peripheral Vasodilator Drugs Consumption Value, 2018-2029
8.3 By Region, Global Peripheral Vasodilator Drugs Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Peripheral Vasodilator Drugs & Forecasts, 2018-2029
8.4.2 By Country, North America Peripheral Vasodilator Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Peripheral Vasodilator Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Peripheral Vasodilator Drugs Market Size Market Share
8.7 South America
8.7.1 South America Peripheral Vasodilator Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Peripheral Vasodilator Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Peripheral Vasodilator Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Peripheral Vasodilator Drugs Consumption Value, 2018-2029
9.3 By Country, Global Peripheral Vasodilator Drugs Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Peripheral Vasodilator Drugs Market Size, 2018-2029
9.4.2 By Type, U.S. Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Peripheral Vasodilator Drugs Market Size, 2018-2029
9.5.2 By Type, Europe Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Peripheral Vasodilator Drugs Market Size, 2018-2029
9.6.2 By Type, China Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Peripheral Vasodilator Drugs Market Size, 2018-2029
9.7.2 By Type, Japan Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Peripheral Vasodilator Drugs Market Size, 2018-2029
9.8.2 By Type, South Korea Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Peripheral Vasodilator Drugs Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Peripheral Vasodilator Drugs Market Size, 2018-2029
9.10.2 By Type, India Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Peripheral Vasodilator Drugs Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer, Inc.
10.1.1 Pfizer, Inc. Company Information, Head Office, Market Area, and Industry Position
10.1.2 Pfizer, Inc. Peripheral Vasodilator Drugs Models, Specifications, and Application
10.1.3 Pfizer, Inc. Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer, Inc. Company Profile and Main Business
10.1.5 Pfizer, Inc. Recent Developments
10.2 Novartis AG
10.2.1 Novartis AG Company Information, Head Office, Market Area, and Industry Position
10.2.2 Novartis AG Peripheral Vasodilator Drugs Models, Specifications, and Application
10.2.3 Novartis AG Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Novartis AG Company Profile and Main Business
10.2.5 Novartis AG Recent Developments
10.3 GSK plc
10.3.1 GSK plc Company Information, Head Office, Market Area, and Industry Position
10.3.2 GSK plc Peripheral Vasodilator Drugs Models, Specifications, and Application
10.3.3 GSK plc Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 GSK plc Company Profile and Main Business
10.3.5 GSK plc Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
10.4.2 AstraZeneca Peripheral Vasodilator Drugs Models, Specifications, and Application
10.4.3 AstraZeneca Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 Merck & Co., Inc.
10.5.1 Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position
10.5.2 Merck & Co., Inc. Peripheral Vasodilator Drugs Models, Specifications, and Application
10.5.3 Merck & Co., Inc. Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Merck & Co., Inc. Company Profile and Main Business
10.5.5 Merck & Co., Inc. Recent Developments
10.6 Sanofi
10.6.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.6.2 Sanofi Peripheral Vasodilator Drugs Models, Specifications, and Application
10.6.3 Sanofi Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sanofi Company Profile and Main Business
10.6.5 Sanofi Recent Developments
10.7 Bayer AG
10.7.1 Bayer AG Company Information, Head Office, Market Area, and Industry Position
10.7.2 Bayer AG Peripheral Vasodilator Drugs Models, Specifications, and Application
10.7.3 Bayer AG Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Bayer AG Company Profile and Main Business
10.7.5 Bayer AG Recent Developments
10.8 Abbott Laboratories
10.8.1 Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position
10.8.2 Abbott Laboratories Peripheral Vasodilator Drugs Models, Specifications, and Application
10.8.3 Abbott Laboratories Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Abbott Laboratories Company Profile and Main Business
10.8.5 Abbott Laboratories Recent Developments
10.9 Bristol-Myers Squibb Company
10.9.1 Bristol-Myers Squibb Company Company Information, Head Office, Market Area, and Industry Position
10.9.2 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Models, Specifications, and Application
10.9.3 Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Bristol-Myers Squibb Company Company Profile and Main Business
10.9.5 Bristol-Myers Squibb Company Recent Developments
10.10 Boehringer Ingelheim International GmbH
10.10.1 Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area, and Industry Position
10.10.2 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Models, Specifications, and Application
10.10.3 Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Boehringer Ingelheim International GmbH Company Profile and Main Business
10.10.5 Boehringer Ingelheim International GmbH Recent Developments
10.11 Teva Pharmaceutical Industries Ltd.
10.11.1 Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
10.11.2 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Models, Specifications, and Application
10.11.3 Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
10.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.12 Viatris, Inc.
10.12.1 Viatris, Inc. Company Information, Head Office, Market Area, and Industry Position
10.12.2 Viatris, Inc. Peripheral Vasodilator Drugs Models, Specifications, and Application
10.12.3 Viatris, Inc. Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Viatris, Inc. Company Profile and Main Business
10.12.5 Viatris, Inc. Recent Developments
10.13 Sun Pharmaceutical Industries Ltd.
10.13.1 Sun Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
10.13.2 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Models, Specifications, and Application
10.13.3 Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Sun Pharmaceutical Industries Ltd. Company Profile and Main Business
10.13.5 Sun Pharmaceutical Industries Ltd. Recent Developments
10.14 Lupin
10.14.1 Lupin Company Information, Head Office, Market Area, and Industry Position
10.14.2 Lupin Peripheral Vasodilator Drugs Models, Specifications, and Application
10.14.3 Lupin Peripheral Vasodilator Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Lupin Company Profile and Main Business
10.14.5 Lupin Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Peripheral Vasodilator Drugs Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Peripheral Vasodilator Drugs Market Restraints
Table 3. Peripheral Vasodilator Drugs Market Trends
Table 4. Peripheral Vasodilator Drugs Industry Policy
Table 5. Global Peripheral Vasodilator Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Peripheral Vasodilator Drugs Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Peripheral Vasodilator Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Peripheral Vasodilator Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Peripheral Vasodilator Drugs Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Peripheral Vasodilator Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Peripheral Vasodilator Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Peripheral Vasodilator Drugs Manufacturers Product Type
Table 13. Head Office and Peripheral Vasodilator Drugs Production Site of Key Manufacturer
Table 14. Peripheral Vasodilator Drugs Capacity of Major Manufacturers and Future Plan
Table 15. China Peripheral Vasodilator Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Peripheral Vasodilator Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Peripheral Vasodilator Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Peripheral Vasodilator Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Peripheral Vasodilator Drugs Production by Region, 2018-2023, (K Units)
Table 20. Global Peripheral Vasodilator Drugs Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Peripheral Vasodilator Drugs Upstream (Raw Materials)
Table 22. Global Peripheral Vasodilator Drugs Typical Customers
Table 23. Peripheral Vasodilator Drugs Typical Distributors
Table 24. By Type, Global Peripheral Vasodilator Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Peripheral Vasodilator Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Peripheral Vasodilator Drugs Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Peripheral Vasodilator Drugs Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Peripheral Vasodilator Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Peripheral Vasodilator Drugs Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Peripheral Vasodilator Drugs Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Peripheral Vasodilator Drugs Sales Quantity Market Share, 2018-2029
Table 34. Pfizer, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer, Inc. Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 36. Pfizer, Inc. Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Pfizer, Inc. Company Profile and Main Business
Table 38. Pfizer, Inc. Recent Developments
Table 39. Novartis AG Company Information, Head Office, Market Area, and Industry Position
Table 40. Novartis AG Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 41. Novartis AG Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Novartis AG Company Profile and Main Business
Table 43. Novartis AG Recent Developments
Table 44. GSK plc Company Information, Head Office, Market Area, and Industry Position
Table 45. GSK plc Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 46. GSK plc Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. GSK plc Company Profile and Main Business
Table 48. GSK plc Recent Developments
Table 49. AstraZeneca Company Information, Head Office, Market Area, and Industry Position
Table 50. AstraZeneca Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 51. AstraZeneca Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. AstraZeneca Company Profile and Main Business
Table 53. AstraZeneca Recent Developments
Table 54. Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position
Table 55. Merck & Co., Inc. Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 56. Merck & Co., Inc. Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Merck & Co., Inc. Company Profile and Main Business
Table 58. Merck & Co., Inc. Recent Developments
Table 59. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 60. Sanofi Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 61. Sanofi Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Sanofi Company Profile and Main Business
Table 63. Sanofi Recent Developments
Table 64. Bayer AG Company Information, Head Office, Market Area, and Industry Position
Table 65. Bayer AG Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 66. Bayer AG Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Bayer AG Company Profile and Main Business
Table 68. Bayer AG Recent Developments
Table 69. Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 70. Abbott Laboratories Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 71. Abbott Laboratories Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Abbott Laboratories Company Profile and Main Business
Table 73. Abbott Laboratories Recent Developments
Table 74. Bristol-Myers Squibb Company Company Information, Head Office, Market Area, and Industry Position
Table 75. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 76. Bristol-Myers Squibb Company Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Bristol-Myers Squibb Company Company Profile and Main Business
Table 78. Bristol-Myers Squibb Company Recent Developments
Table 79. Boehringer Ingelheim International GmbH Company Information, Head Office, Market Area, and Industry Position
Table 80. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 81. Boehringer Ingelheim International GmbH Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Boehringer Ingelheim International GmbH Company Profile and Main Business
Table 83. Boehringer Ingelheim International GmbH Recent Developments
Table 84. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 85. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 86. Teva Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Teva Pharmaceutical Industries Ltd. Company Profile and Main Business
Table 88. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 89. Viatris, Inc. Company Information, Head Office, Market Area, and Industry Position
Table 90. Viatris, Inc. Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 91. Viatris, Inc. Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Viatris, Inc. Company Profile and Main Business
Table 93. Viatris, Inc. Recent Developments
Table 94. Sun Pharmaceutical Industries Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 95. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 96. Sun Pharmaceutical Industries Ltd. Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Sun Pharmaceutical Industries Ltd. Company Profile and Main Business
Table 98. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 99. Lupin Company Information, Head Office, Market Area, and Industry Position
Table 100. Lupin Peripheral Vasodilator Drugs Models, Specifications, and Application
Table 101. Lupin Peripheral Vasodilator Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Lupin Company Profile and Main Business
Table 103. Lupin Recent Developments
List of Figures
Figure 1. Peripheral Vasodilator Drugs Picture
Figure 2. Global Peripheral Vasodilator Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Peripheral Vasodilator Drugs Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Peripheral Vasodilator Drugs Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Peripheral Vasodilator Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Peripheral Vasodilator Drugs Sales Quantity (K Units) & (2018-2029)
Figure 7. China Peripheral Vasodilator Drugs Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Peripheral Vasodilator Drugs Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Peripheral Vasodilator Drugs Market Share of Global, 2018-2029
Figure 10. Global Peripheral Vasodilator Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Peripheral Vasodilator Drugs Key Participants, Market Share, 2022
Figure 12. Global Peripheral Vasodilator Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Peripheral Vasodilator Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Peripheral Vasodilator Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 15. Peripheral Vasodilator Drugs Industry Chain
Figure 16. Peripheral Vasodilator Drugs Procurement Model
Figure 17. Peripheral Vasodilator Drugs Sales Model
Figure 18. Peripheral Vasodilator Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Calcium Channel Blockers
Figure 20. Alpha-adrenergic Blockers
Figure 21. Potassium Channel Activators
Figure 22. Others
Figure 23. By Type, Global Peripheral Vasodilator Drugs Consumption Value, 2018-2029, US$ Million
Figure 24. By Type, Global Peripheral Vasodilator Drugs Consumption Value Market Share, 2018-2029
Figure 25. By Type, Global Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 26. By Type, Global Peripheral Vasodilator Drugs Sales Quantity Market Share, 2018-2029
Figure 27. By Type, Global Peripheral Vasodilator Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 28. Hospital
Figure 29. Retail Pharmacies
Figure 30. Others
Figure 31. By Application, Global Peripheral Vasodilator Drugs Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Peripheral Vasodilator Drugs Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 34. By Application, Global Peripheral Vasodilator Drugs Sales Quantity Market Share, 2018-2029
Figure 35. By Application, Global Peripheral Vasodilator Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 36. By Region, Global Peripheral Vasodilator Drugs Consumption Value Market Share, 2018-2029
Figure 37. By Region, Global Peripheral Vasodilator Drugs Sales Quantity Market Share, 2018-2029
Figure 38. North America Peripheral Vasodilator Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, North America Peripheral Vasodilator Drugs Consumption Value Market Share, 2022
Figure 40. Europe Peripheral Vasodilator Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country, Europe Peripheral Vasodilator Drugs Consumption Value Market Share, 2022
Figure 42. Asia Pacific Peripheral Vasodilator Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country/Region, Asia Pacific Peripheral Vasodilator Drugs Consumption Value Market Share, 2022
Figure 44. South America Peripheral Vasodilator Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, South America Peripheral Vasodilator Drugs Consumption Value Market Share, 2022
Figure 46. Middle East & Africa Peripheral Vasodilator Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 47. U.S. Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, U.S. Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, U.S. Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 50. Europe Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, Europe Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, Europe Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 53. China Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, China Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, China Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 56. Japan Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, Japan Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, Japan Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 59. South Korea Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, South Korea Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, South Korea Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 62. Southeast Asia Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, Southeast Asia Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, Southeast Asia Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 65. India Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, India Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, India Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 68. Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity, 2018-2029, (K Units)
Figure 69. By Type, Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, Middle East & Africa Peripheral Vasodilator Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 71. Research Methodology
Figure 72. Breakdown of Primary Interviews
Figure 73. Bottom-up and Top-down Approaches
Figure 74. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|